CYP19 Genetic Polymorphism & Aromatase Inhibitor(AI)
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Breast Neoplasms|Arthralgia|Arthritis|Genetic Polymorphism
Interventions: DRUG: Aromatase Inhibitor(Femara or Arimidex)
Sponsor: Korea University Anam Hospital
Collaborators: Korea University